Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lipase, endothelial | Starlite/ChEMBL | No references |
Homo sapiens | lipase, hepatic | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | beta tubulin, putative | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0158 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin, beta 4A class IVa | 0.0158 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Plasmodium falciparum | tubulin beta chain | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin, putative | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | beta tubulin | 0.0158 | 0.5 | 0.5 |
Plasmodium vivax | tubulin beta chain, putative | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0158 | 0.5 | 0.5 |
Toxoplasma gondii | beta-tubulin, putative | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta chain | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | beta tubulin | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin beta 1 chain | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.0158 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0158 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0158 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin beta 1 chain | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | beta tubulin | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin beta 4A class IVa | 0.0158 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-2A chain | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0158 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-4 chain | 0.0158 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0158 | 0.5 | 0.5 |
Toxoplasma gondii | beta tubulin | 0.0158 | 0.5 | 0.5 |
Brugia malayi | beta-tubulin, identical | 0.0158 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0158 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0158 | 0.5 | 0.5 |
Echinococcus multilocularis | beta tubulin | 0.0158 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0158 | 0.5 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0158 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-1 chain | 0.0158 | 0.5 | 0.5 |
Loa Loa (eye worm) | beta-tubulin | 0.0158 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.1 nM | Biological Assay | BINDINGDB. | No reference |
IC50 (binding) | = 36.5 nM | BindingDB_Patents: Biological Assay. Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artificial vesicle containing DMPG (Avanti Polar Lipids) as the excipient. Vesicles were prepared by combining 571 uL of 29 mM DMPG in a 1:1 mixture of MeOH and CHCl3 with 2000 uL of 1 mM A10070 in a 1:1 mixture of MeOH and CHCl3. The mixture was dried under nitrogen in multiple vials then resuspended in 20 mL total volume of 50 mM HEPES pH 8.0 buffer containing 50 mM NaCl and 0.2 mM EDTA. The sample was allowed to sit at room temperature for 15 min and then was sonicated 3x4 mins on ice with a Branson Sonicator using duty cycle 1. This preparation provides vesicles with a mole fraction of 0.11 for the FRET substrate.The enzymatic assay was measured using 384-well white Optiplates. Each well contained 20 uL of assay buffer (50 mM HEPES pH 8.0, 50 mM NaCl and 1 mM CaCl2) and 0.25 uL of a DMSO solution containing a compound. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.